Phase I study of the 177Lu-DOTA0-Tyr3-Octreotate (lutathera) in combination with nivolumab in patients with neuroendocrine tumors of the lung
published in: Journal for Immunotherapy of Cancer
date of publication: 2020-07-01
Cites articles
There is nothing here
Article - wd:Q96949822